Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571174
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisEli Lilly and CompanyNot Yet RecruitingPhase 1
NCT07571174Not Yet Recruiting
Phase 1
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclero...Eli Lilly and Company
NCT07569523
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNot Yet Recruiting
NCT07569523Not Yet Recruiting
—
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Rece...
NCT07570134
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei UniversityNot Yet RecruitingNot Applicable
NCT07570134Not Yet Recruiting
Not Applicable
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei University
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07569276
Effects of an Experimental Propolis Gel on Tooth Sensitivity Control and Post-bleaching Color Change: a Randomized Clinical TrialUniversidade Federal do ParaNot Yet RecruitingNot Applicable
NCT07569276Not Yet Recruiting
Not Applicable
Effects of an Experimental Propolis Gel on Tooth Sensitivity Control and Post-bl...Universidade Federal do P...
NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeGlaxoSmithKlineNot Yet RecruitingPhase 2
NCT07569081Not Yet Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With V...GlaxoSmithKline
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerNovartis PharmaceuticalsRecruitingPhase 1
NCT07570979Recruiting
Phase 1
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent o...Novartis Pharmaceuticals
NCT07569783
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Nantong UniversityNot Yet RecruitingNot Applicable
NCT07569783Not Yet Recruiting
Not Applicable
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Na...
NCT07568769
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of FaisalabadCompletedNot Applicable
NCT07568769Completed
Not Applicable
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of Faisalabad
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571330
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de Nuevo LeonRecruitingNot Applicable
NCT07571330Recruiting
Not Applicable
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de N...
NCT07568782
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.Lille UniversityNot Yet Recruiting
NCT07568782Not Yet Recruiting
—
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Im...Lille University
NCT07570810
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMShanghai Jiao Tong University School of MedicineNot Yet RecruitingNot Applicable
NCT07570810Not Yet Recruiting
Not Applicable
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD...Shanghai Jiao Tong Univer...
NCT07571447
Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial FibrillationGødstrup HospitalNot Yet RecruitingPhase 4
NCT07571447Not Yet Recruiting
Phase 4
Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Seda...Gødstrup Hospital
NCT07571304
Dual-Task Training in Pediatric Multiple SclerosisIstanbul University - CerrahpasaRecruitingNot Applicable
NCT07571304Recruiting
Not Applicable
Dual-Task Training in Pediatric Multiple SclerosisIstanbul University - Cer...
NCT07571031
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell CarcinomaFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07571031Not Yet Recruiting
—
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of...Fondazione Policlinico Un...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting6 (30%)
Completed2 (10%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 12 (10%)
Phase 42 (10%)